Group 9 metal-based inhibitors of β-amyloid (1-40) fibrillation as potential therapeutic agents for Alzheimer's disease

Keyphrases

• Alzheimer's Disease 100%
• Iridium 100%
• Potential Therapeutics 100%
• Fibrillation 100%
• Metal-based Inhibitors 100%
• Group 9 Metals 100%
• Co-ligand 100%
• Aromatics 50%
• Rhodium 50%
• Luminescent Probe 50%
• Metal Complexes 50%
• Transition Metal Complexes 50%
• Bond Formation 50%
• Peptide Aggregation 50%
• Fibrillogenesis 50%
• Luminescence Detection 50%
• Histidine Residue 50%
• Coordination Bond 50%
• Hydrophobic Residues 50%
• First Application 50%
• N-terminal Domain 50%

Chemistry

• Luminiscence Type 100%
• Iridium 100%
• formation 50%
• Rhodium 50%
• Coordination Compound 50%
• Histidine 50%